Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.

about

Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.

Item

http://www.wikidata.org/entity/Q43088347

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.

@en

Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.

@nl

type

Item

label

Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.

@en

Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.

@nl

prefLabel

Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.

@en

Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.

@nl

P1476

Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.

@en

P2093

Andras Kiss

http://www.w3.org/2001/XMLSchema#string

Diego F Calvisi

http://www.w3.org/2001/XMLSchema#string

Dongchi Zhao

http://www.w3.org/2001/XMLSchema#string

Frank Dombrowski

http://www.w3.org/2001/XMLSchema#string

Li Che

http://www.w3.org/2001/XMLSchema#string

Pin Liu

http://www.w3.org/2001/XMLSchema#string

Silvia Ribback

http://www.w3.org/2001/XMLSchema#string

Xin Chen

http://www.w3.org/2001/XMLSchema#string

Zsuzsa Schaff

http://www.w3.org/2001/XMLSchema#string

P2860

mTOR signaling in growth control and disease

Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver

Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot

A Call for Systematic Research on Solute Carriers

Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends

Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas

The epidemiology of hepatoblastoma

Solute carriers as drug targets: current use, clinical trials and prospective.

FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma.

New concepts and outcomes for children with hepatoblastoma based on the experience of a tertiary center over the last 21 years.

P304

73433-73447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20622

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Cigliano

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29088718

http://www.w3.org/2001/XMLSchema#string

P932

5650273

http://www.w3.org/2001/XMLSchema#string